Search

Displaying results 301 - 310 of 10000 in total
  1. Drug

    Zolpidem

    go.drugbank.com/drugs/DB00425
    ApprovedInvestigational

    Zolpidem, also known as _Ambien_, is a hypnotic drug that was initially approved by the FDA in 1992 [FDA label]. Zolpidem improves sleep in patients with insomnia. … In addition, zolpidem improves sleep quality in patients suffering from chronic insomnia and can show mild muscle relaxant properties [L5584].

    Synonyms: N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamideProducts: ZOLPIDEM EG, Zolpidem Tartrate ER
  2. Drug

    Fondaparinux

    go.drugbank.com/drugs/DB00569
    ApprovedInvestigational

    Fondaparinux (Arixtra) is a synthetic anticoagulant agent consisting of five monomeric sugar units and a O-methyl group at the reducing end of the molecule. … Fondaparinux may be used: to prevent venous thromboembolism in patients who have undergone orthopedic surgery of the lower limbs (e.g. hip fracture, hip replacement and knee surgery); to prevent VTE in

    Products: ENJ. COZELTI ICEREN KULLANIMA HAZIR SIRINGA, 2 ADET, ENJ. COZELTI ICEREN KULLANIMA HAZIR SIRINGA, 10 ADET
  3. Drug

    Bisacodyl

    go.drugbank.com/drugs/DB09020
    ApprovedInvestigational

    [A233290,A233300,A207700] Bisacodyl was patented on 25 September 1956[L33045] but has been used as a laxative since 1952.[A233300]

    Products: Soflax EX 5, Soflax EX 10
  4. Drug

    Quinapril

    go.drugbank.com/drugs/DB00881
    ApprovedInvestigational

    [L8420,L8423] ACE inhibitors are commonly used as a first line therapy in the treatment of hypertension, along with thiazide diuretics or beta blockers. … [A184844] Quinapril was granted FDA approval on 19 November 1991.[L8420] A combination tablet with [hydrochlorothiazide] was also approved on 28 December 1999.[L8423]

    Mixtures: QUINAPRIL IDROCLOROTIAZIDE EG, QUINAPRIL IDROCLOROTIAZIDE EGCategories: Agents Acting on the Renin-Angiotensin System
  5. Drug

    Isosorbide mononitrate

    go.drugbank.com/drugs/DB01020
    ApprovedInvestigational

    Isosorbide mononitrate is an organic nitrate with vasodilating properties. … [L11698, L11743] Isosorbide mononitrate is an active metabolite of [isosorbide dinitrate].

    Categories: Vasodilators Used in Cardiac DiseasesSynonyms: IS 5-MN, IS-5-MN
  6. Drug

    Pheniramine

    go.drugbank.com/drugs/DB01620
    Approved

    [A181628] It is used in some over-the-counter allergy as well as cold & flu products in combination with other drugs. … Pheniramine is a first-generation antihistamine in the alkylamine class, similar to [brompheniramine] and [chlorpheniramine].

    Mixtures: OCTILIA ALLERGIA E INFIAMMAZIONE, OCTILIA ALLERGIA E INFIAMMAZIONEProducts: FENAMED 45,5 MG/2 ML IM/IV ENJ. COZ. ICEREN 50 AMPUL, FENAMED 45,5 MG/2 ML IM/IV ENJ. COZ. ICEREN AMPUL, 5 ADET
  7. Drug

    Methoxy polyethylene glycol-epoetin beta

    go.drugbank.com/drugs/DB09107
    ApprovedInvestigational

    Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent (ESA) with a longer half-life than erythropoietin. ESA is used to increase synthesis of red blood cells to treat chronic kidney disease...

    Categories: Compounds used in a research, industrial, or household settingProducts: MIRCERA ROCHE 30 MCG/0,3 ML SC/IV ENJ. ICIN KULLANIMA HAZIR SIRINGA, MIRCERA ROCHE 50 MCG/0,3 ML SC/IV ENJ. ICIN KULLANIMA HAZIR SIRINGA
  8. Drug

    Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

    go.drugbank.com/drugs/DB16443
    Investigational

    It also provided protection in non-human primates to an in vivo challenge with SARS-CoV-2[A226853]. … The Recombinant SARS-CoV-2 Vaccine was created by inserting genes of the SARS-CoV-2 spike protein’s receptor-binding domain into a baculovirus expression system[F4738, A226853].

  9. Drug

    Urokinase

    go.drugbank.com/drugs/DB00013
    ApprovedInvestigationalWithdrawn

    Urokinase is an endogenous peptide that is cleaved in the presence of plasmin between lysine 158 and isoleucine 159 to yield active urokinase. … [A191943] Urokinase was granted FDA approval on 16 January 1978.[L12138]

    Products: UROCHINASI EG
  10. Drug

    Thiotepa

    go.drugbank.com/drugs/DB04572
    ApprovedInvestigational

    It is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. … N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years.

    Synonyms: N,N′,N′′-tri-1,2-ethanediyl-, Phosphorothioic triamide, N,N′,N′′-tri-1,2-ethanediyl-Products: Thiotepa Fresenius Kabi 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Thiotepa Fresenius Kabi 15 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung